Dirk Jäger

Heidelberg University — Germany

Immunology and Microbiology · Life Sciences

42h-index9.4kcitations211works4.42yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Immunotherapy and Immune Responses(51), Cancer Immunotherapy and Biomarkers(38), Gastric Cancer Management and Outcomes(26), Colorectal Cancer Treatments and Studies(26), Immune Cell Function and Interaction(16)

Publications209 total

Abstract B055: Optimizing longitudinal peripheral blood–based immune monitoring in cancer patients by single-cell mass cytometry
Cancer Immunology Research·2026
Delivering precision oncology in metastatic breast cancer: Clinical impact of comprehensive genomic profiling—The <scp>CATCH</scp> experience
International Journal of Cancer·2025Open Access
ESPEC-SUIT: a versatile and robust platform to identify and track antigen-specific T cell receptors in patients with cancer
Journal for ImmunoTherapy of Cancer·2025· 1 citedOpen Access
Monitoring soluble cMET and ctDNA in metastatic uveal melanoma patients to track early disease progression on immunotherapies
Journal of Experimental & Clinical Cancer Research·2025· 2 citedOpen Access
Selective neoadjuvant therapy of rectal cancer patients (SELREC): study protocol for a European randomised controlled, open, multicentre non-inferiority trial
BMJ Open·2025Open Access
Optimization of multiprofessional care for young colorectal cancer patients: a qualitative Study
The Oncologist·2025· 1 citedOpen Access
<scp>WNT5a</scp> export onto extracellular vesicles studied at single‐molecule and single‐vesicle resolution
FEBS Journal·2025· 2 citedOpen Access
Efficacy of Hand Cooling and Compression in Preventing Taxane-Induced Neuropathy
JAMA Oncology·2025· 22 cited
Biopsychosoziales Belastungsscreening für Patient*innen am Nationalen Centrum für Tumorerkrankungen Heidelberg
Die Onkologie·2025· 1 cited
Image-based screens identify regulators of endogenous Dvl2 biomolecular condensates
2025Open Access
Improved survival of patients with newly diagnosed oligometastatic prostate cancer through intensified multimodal treatment
Frontiers in Oncology·2024· 1 citedOpen Access
Feasibility, Tolerability, and Preliminary Clinical Response of Fractionated Radiopharmaceutical Therapy with<sup>213</sup>Bi-FAPI-46: Pilot Experience in Patients with End-Stage, Progressive Metastatic Tumors
Journal of Nuclear Medicine·2024· 5 citedOpen Access
Abstract 6968: Extracellular vesicles as carriers of signaling factors in cancer
Cancer Research·2024Open Access
Primary Tumor Resection Before Systemic Therapy in Patients With Colon Cancer and Unresectable Metastases: Combined Results of the SYNCHRONOUS and CCRe-IV Trials
Journal of Clinical Oncology·2024· 26 cited
Initial results from a first-in-human, phase I study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964 in patients with advanced solid tumors.
Journal of Clinical Oncology·2023· 11 cited
Abstract CT276: Preliminary analysis of pharmacokinetic (PK) and target engagement biomarkers from a first in human phase 1 study of immunomodulatory aryl hydrocarbon receptor (AhR) inhibitor BAY2416964
Cancer Research·2023· 1 cited
Supplementary Table S1 from Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients
2023Open Access
Supplementary Figure S3 from Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients
2023Open Access
Data from Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients
2023Open Access
Supplementary Figure S4 from Antibody Responses to Cancer Antigens Identify Patients with a Poor Prognosis among HPV-Positive and HPV-Negative Head and Neck Squamous Cell Carcinoma Patients
2023Open Access
page 1 of 11Next →

Frequent Co-authors

Alexander Knuth(18), Elke Jäger(15), Lloyd J. Old(13), Yao‐Tseng Chen(11), Jürgen Debus(8), Elisabeth Stockert(8), Markus W. Büchler(7), Thomas Lindner(6), Frederik L. Giesel(6), Clemens Kratochwil(6), Walter Mier(6), Julia Karbach(6), Gerd Ritter(6), Matthew J. Scanlan(6), Annette Altmann(5), Uwe Haberkorn(5), Niels Halama(5), Jürgen Weitz(5), Dung T. Le(4), Takayuki Yoshino(4)